Subscribe
  • Redeem your points

Search

Primary links

  • Home
  • Companies
    Biotechnology Semiconductors Consumer Products and Services
    Industrial/Energy Medical Devices and Equipment Media and Entertainment IT Services Networking and Equipment Electronics/Instrumentation Software Wireless Financial Services Telecommunications Computers and Peripherals Retailing/Distribution Business Products and Services Healthcare Services Other
  • Press
  • Jobs
  • Blogs
    Apple Mobile
    Business Dev & Design Entertainment Social Media Tech Web Video
  • Videos
    Apple Mobile
    Business Dev & Design Entertainment Social Media Tech Web Video
  • Forum

Hydra Biosciences Inc

Hydra Biosciences Inc

No votes yet

Develops medicines and drugs targeting ion channels.

Year Established:
Funding: 22
Address:

Hydra Biosciences, Inc. 790 Memorial Drive, off Pleasant Street Cambridge, MA 02139

Telephone: 2147483647
Mobile:
Fax: 6174945245
Mail: info@hydrabiosciences.com
Company URL: http://www.hydrabiosciences.com

blocks_tabs

  • Job Listings
  • Press Releases
  • Industry Experts
  • Tech Community Rating
  • Investors
  • Management Team

Thank you for your interest in Hydra Biosciences. We are always seeking talented people who are looking for a challenging and rewarding work experience. Please send your resume to jobs@hydrabiosciences.com. Openings can become available at any time.

  • October 19, 2009
    Hydra Biosciences and Cubist Form Collaboration to Develop Novel Ion Channel Drugs for Pain Management
  • May 18, 2009
    Research published in PNAS by Hydra Biosciences is First Demonstration in Mammals that TRP Ion Channel Drug Can Treat Allergy-Induced Asthma
  • January 20, 2009
    Emerging Drug Developer: Hydra Biosciences (FierceBiotech)
  • January 16, 2009
    Hydra Brings in $22M in Series D to Push First Program into Clinic (BioWorld Today)
  • January 16, 2009
    Hydra Biosciences Reaps $22.2M Series D (Dow Jones VentureWire)
  • January 16, 2009
    Hydra Biosciences Raises $22M to Create New Pain Relievers With Fewer Side Effects (Xconomy)
  • January 16, 2009
    Hydra garners $22M for ion channel programs (FierceBiotech)
  • January 16, 2009
    Hydra Biosciences Raises $22 Million in Series D Financing
  • October 24, 2008
    Hydra Biosciences Bolsters Discovery and IP Capabilities with Key Additions to Executive Management Team
  • January 2, 2008
    Hydra Biosciences CEO Russell Herndon Interviewed on NECN (QuickTime movie, 7 MB)
  • November 16, 2007
    Hydra Biosciences Featured in Mass High Tech Article
  • August 14, 2007
    Hydra Biosciences Publishes Article in PNAS Demonstrating that TRPA1 Mediates Formalin-Induced Pain
  • August 7, 2007
    Hydra Biosciences Announces Data Revealing the Crucial Role Played by the TRPA1 Ion Channel in a Standard Model of Pain Receptor Activation
  • July 26, 2007
    Hydra Biosciences and Pfizer Global Research & Development Sign Collaboration Agreement
  • April 25, 2006
    Hydra Biosciences Co-founder Dr. David Clapham Elected to the National Academy of Sciences
  • January 26, 2006
    Regeneration Sans Stem Cells
  • January 5, 2006
    Hydra Biosciences Appoints Russell H. Herndon as Chief Executive Officer
  • April 1, 2005
    Sophion and Hydra Establish a Unique Reference Site for QPatch Automated Patch Clamp System
  • April 26, 2004
    Hydra Biosciences Co-founder Dr. Mark Keating Elected to the National Academy of Sciences
  • January 12, 2004
    Hydra Biosciences Raises $18.875 Million in Series B Financing
  • December 4, 2003
    Hydra Biosciences Appoints Glenn R. Larsen, Ph.D. as Chief Scientific Officer
  • November 2003
    Regrow Your Own - Broken heart? No problem. New liver? Coming right up. The road to regeneration starts here.
  • July 25, 2002
    Hydra Biosciences, a Biopharmaceuticals Company Developing Molecular Regeneration Medicines, Secures $10 Million in Series A Funding

Advanced Technology Ventures,BioVentures Investors,Polaris Venture Partners

Glenn Larsen
Chief Operating Officer and Executive Vice President of Development
Russell Herndon
President and Chief Executive Officer
Tom Burke
Vice President of Finance and Treasurer
David Kimball
Chief Scientific Officer

  • Home
  • Companies
  • Biotechnology
  • IT Industry
  • Industrial/Energy
  • Medical Devices and Equipment
  • Media and Entertainment
  • IT Services
  • Networking and Equipment
  • Semiconductors
  • Electronics/Instrumentation
  • Software
  • Wireless
  • Financial Services
  • Telecommunications
  • Consumer Products and Services
  • Computers and Peripherals
  • Retailing/Distribution
  • Business Products and Services
  • Healthcare Services
  • Other
  • Press
  • Blogs
  • Blogs
  • Apple
  • Business
  • Dev & Design
  • Entertainment
  • Mobile
  • Social Media
  • Tech
  • Web Video
  • Videos
  • Apple
  • Business
  • Dev & Design
  • Entertainment
  • Mobile
  • Social Media
  • Tech
  • Web Video
  • Forum
  • Home
  • Companies
  • Biotechnology
  • Industrial/Energy
  • Medical Devices and Equipment
  • Media and Entertainment
  • IT Services
  • Networking and Equipment
  • Semiconductors
  • Electronics/Instrumentation
  • Software
  • Wireless
  • Financial Services
  • Telecommunications
  • Consumer Products and Services
  • Computers and Peripherals
  • Retailing/Distribution
  • Business Products and Services
  • Healthcare Services
  • Other
  • Press
  • Blogs